This topic contains a solution. Click here to go to the answer

Author Question: Restricting access to the ________ requires the user to use the user interface you have developed. ... (Read 106 times)

maychende

  • Hero Member
  • *****
  • Posts: 556
Restricting access to the ________ requires the user to use the user interface you have developed.
 
  A) Navigation Pane
  B) navigation form
  C) startup form
  D) command buttons

Question 2

The ________ Web App gives every member of the team the option to review notes and specifications written by other team members.
 
  Fill in the blank(s) with correct word



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

CourtneyCNorton

  • Sr. Member
  • ****
  • Posts: 317
Answer to Question 1

A

Answer to Question 2

OneNote




maychende

  • Member
  • Posts: 556
Reply 2 on: Aug 28, 2018
Great answer, keep it coming :)


jackie

  • Member
  • Posts: 324
Reply 3 on: Yesterday
Thanks for the timely response, appreciate it

 

Did you know?

On average, the stomach produces 2 L of hydrochloric acid per day.

Did you know?

Over time, chronic hepatitis B virus and hepatitis C virus infections can progress to advanced liver disease, liver failure, and hepatocellular carcinoma. Unlike other forms, more than 80% of hepatitis C infections become chronic and lead to liver disease. When combined with hepatitis B, hepatitis C now accounts for 75% percent of all cases of liver disease around the world. Liver failure caused by hepatitis C is now leading cause of liver transplants in the United States.

Did you know?

Critical care patients are twice as likely to receive the wrong medication. Of these errors, 20% are life-threatening, and 42% require additional life-sustaining treatments.

Did you know?

Women are two-thirds more likely than men to develop irritable bowel syndrome. This may be attributable to hormonal changes related to their menstrual cycles.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

For a complete list of videos, visit our video library